131 related articles for article (PubMed ID: 17122957)
1. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo.
Slotta JE; Braun OO; Menger MD; Thorlacius H
Inflamm Res; 2006 Sep; 55(9):364-7. PubMed ID: 17122957
[TBL] [Abstract][Full Text] [Related]
2. Central role of rho kinase in lipopolysaccharide-induced platelet capture on venous endothelium.
Slotta JE; Braun OO; Menger MD; Thorlacius H
J Investig Med; 2008 Apr; 56(4):720-5. PubMed ID: 18382268
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
[TBL] [Abstract][Full Text] [Related]
4. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
5. Fasudil inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2.
Wang J; Xu J; Zhao X; Xie W; Wang H; Kong H
Exp Cell Res; 2018 Apr; 365(1):97-105. PubMed ID: 29481792
[TBL] [Abstract][Full Text] [Related]
6. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
[TBL] [Abstract][Full Text] [Related]
7. Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion.
Santen S; Wang Y; Laschke MW; Menger MD; Jeppsson B; Thorlacius H
Int J Colorectal Dis; 2010 Sep; 25(9):1063-70. PubMed ID: 20593289
[TBL] [Abstract][Full Text] [Related]
8. Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162.
Slotta JE; Braun OO; Menger MD; Thorlacius H
Platelets; 2009 Nov; 20(7):505-12. PubMed ID: 19852690
[TBL] [Abstract][Full Text] [Related]
9. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
[TBL] [Abstract][Full Text] [Related]
11. Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges.
Taki F; Kume H; Kobayashi T; Ohta H; Aratake H; Shimokata K
Clin Exp Allergy; 2007 Apr; 37(4):599-607. PubMed ID: 17430358
[TBL] [Abstract][Full Text] [Related]
12. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase.
McGown CC; Brown NJ; Hellewell PG; Brookes ZL
Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186
[TBL] [Abstract][Full Text] [Related]
13. Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs.
Suzuki K; Nemoto K; Ninomiya N; Kuno M; Kubota M; Yokota H
J Surg Res; 2012 Nov; 178(1):352-7. PubMed ID: 22487385
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
[TBL] [Abstract][Full Text] [Related]
15. Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice.
Steioff K; Rütten H; Busch AE; Plettenburg O; Ivashchenko Y; Löhn M
Eur J Pharmacol; 2005 Apr; 512(2-3):247-9. PubMed ID: 15840411
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.
Wang QM; Stalker TJ; Gong Y; Rikitake Y; Scalia R; Liao JK
Vasc Med; 2012 Dec; 17(6):379-85. PubMed ID: 23015643
[TBL] [Abstract][Full Text] [Related]
17. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
18. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.
Nohria A; Grunert ME; Rikitake Y; Noma K; Prsic A; Ganz P; Liao JK; Creager MA
Circ Res; 2006 Dec; 99(12):1426-32. PubMed ID: 17095725
[TBL] [Abstract][Full Text] [Related]
19. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits.
Furuyama T; Komori K; Shimokawa H; Matsumoto Y; Uwatoku T; Hirano K; Maehara Y
J Vasc Surg; 2006 Jun; 43(6):1249-56. PubMed ID: 16765249
[TBL] [Abstract][Full Text] [Related]
20. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
